Results 211 to 220 of about 201,878 (263)
Some of the next articles are maybe not open access.
Circumlimbal Carcinoma-in-Situ
Archives of Ophthalmology, 1965The purpose of this paper is to report an unusual case of carcinoma-in-situ which presented as a 360° circumlimbal growth. Report of Case A 70-year-old white male was first seen two and a half years prior to admission. At that time visual acuity in the right eye was 20/100.
openaire +2 more sources
Journal of Surgical Oncology, 1980
AbstractLobular carcinoma in situ remains controversial in nomenclature, histology, and therapy. The original description and therapeutic recommendations remain a significant contribution to better control of breast cancer. We believe the sophistication of mammography, not available at the time of the earliest therapeutic recommednations, provides the ...
R W, Powers, P H, O'Brien, A, Kreutner
openaire +2 more sources
AbstractLobular carcinoma in situ remains controversial in nomenclature, histology, and therapy. The original description and therapeutic recommendations remain a significant contribution to better control of breast cancer. We believe the sophistication of mammography, not available at the time of the earliest therapeutic recommednations, provides the ...
R W, Powers, P H, O'Brien, A, Kreutner
openaire +2 more sources
Australian and New Zealand Journal of Obstetrics and Gynaecology, 1970
Summary: Two series of cases, one of 576 patients with cervical carcinoma in situ, and one of 1,235 patients with invasive carcinoma, both diagnosed and managed in the years 1946 to 1967 at National Women's Hospital, are presented; follow‐up of both series is 100%. Except for a special series of 27 patients diagnosed and treated by punch biopsy alone,
openaire +2 more sources
Summary: Two series of cases, one of 576 patients with cervical carcinoma in situ, and one of 1,235 patients with invasive carcinoma, both diagnosed and managed in the years 1946 to 1967 at National Women's Hospital, are presented; follow‐up of both series is 100%. Except for a special series of 27 patients diagnosed and treated by punch biopsy alone,
openaire +2 more sources
Surgical Clinics of North America, 2013
Management of ductal carcinoma in situ (DCIS) has evolved from radical surgery to the option of a more minimally invasive approach. Data show that breast conservation surgery performed with administration of radiotherapy, like mastectomy, is feasible and safe.
openaire +2 more sources
Management of ductal carcinoma in situ (DCIS) has evolved from radical surgery to the option of a more minimally invasive approach. Data show that breast conservation surgery performed with administration of radiotherapy, like mastectomy, is feasible and safe.
openaire +2 more sources
Archives of Surgery, 1989
A total of 150 patients with in situ breast cancer were treated from 1970 through 1976, with a median follow-up of 11.5 years. There were 42 patients with microinvasion and 25 with bilateral disease, analyzed separately. Eight patients who became unavailable for follow-up within five years (but who had no evidence of disease [NED]) were excluded ...
D W, Kinne +5 more
openaire +2 more sources
A total of 150 patients with in situ breast cancer were treated from 1970 through 1976, with a median follow-up of 11.5 years. There were 42 patients with microinvasion and 25 with bilateral disease, analyzed separately. Eight patients who became unavailable for follow-up within five years (but who had no evidence of disease [NED]) were excluded ...
D W, Kinne +5 more
openaire +2 more sources
Carcinoma In Situ in Pregnancy
JAMA, 1961Carcinoma in situ is a frequent finding in pregnancy when cytologic methods are applied as a routine screening procedure. Such testing has been done without risk and has been applied at all stages. Cancer found when unsuspected and in a preclinical state rarely demands radical treatment.
J E, AYRE, J W, SCOTT
openaire +2 more sources
1996
In the past 10 years clinical trials have confirmed the value of breast conserving therapy for invasive breast cancer and many authorities now consider this the preferred and appropriate treatment (NCI Consensus Statement 1992a). However controversy still surrounds the treatment of ductal carcinoma in situ (DCIS).
openaire +2 more sources
In the past 10 years clinical trials have confirmed the value of breast conserving therapy for invasive breast cancer and many authorities now consider this the preferred and appropriate treatment (NCI Consensus Statement 1992a). However controversy still surrounds the treatment of ductal carcinoma in situ (DCIS).
openaire +2 more sources
Breast Disease, 2001
Ductal carcinoma in situ (DCIS) has become a predominant pathologic entity with the broad implementation of screening mammography. In the premammographic era, it represented less than 10% of all breast cancers. Although it now occupies as much as 30% of contemporary series, it remains a controversial subject of debate in terms of its management.
openaire +2 more sources
Ductal carcinoma in situ (DCIS) has become a predominant pathologic entity with the broad implementation of screening mammography. In the premammographic era, it represented less than 10% of all breast cancers. Although it now occupies as much as 30% of contemporary series, it remains a controversial subject of debate in terms of its management.
openaire +2 more sources
1985
This lesion has also been called ‘flat carcinoma in situ’ (Riddle et al. 1976) or ‘flat intraepithelial neoplasia’ (Barlebo et al. 1972). These are attempts to define the epithelial abnormality where there is an overtly malignant cellular pattern of the epithelial cells but without invasion or papillary growth.
openaire +1 more source
This lesion has also been called ‘flat carcinoma in situ’ (Riddle et al. 1976) or ‘flat intraepithelial neoplasia’ (Barlebo et al. 1972). These are attempts to define the epithelial abnormality where there is an overtly malignant cellular pattern of the epithelial cells but without invasion or papillary growth.
openaire +1 more source